 1 Agents affecting nervous system and sensory organs
|
|
2 Agents affecting individual organs
|
|
3 Agents affecting metabolism
|
|
4 Agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
 6 Agents against pathologic organisms and parasites
|
61 Antibiotics
|
611 Acting mainly on gram-positive bacteria
|
612 Acting mainly on gram-negative bacteria
|
613 Acting mainly on gram-positive and gram-negative bacteria
|
6131 Penicillins
|
6132 Cephem antibioitics
|
 D00263 Cefalexin (JP18)
D00907 Cephalothin sodium (USP); Cefalotin sodium (JP18)
D00905 Cefazolin sodium (JP18/USP)
D02226 Cefazolin sodium hydrate (JP18)
D05026 Cefroxadine hydrate (JP18)
D00914 Cefuroxime axetil (JP18/USP/INN)
D00256 Cefaclor (JP18)
D01819 Cefotiam hydrochloride (JP18/USP)
D00911 Cefmetazole sodium (JP18/USP)
D01909 Cefminox sodium hydrate (JP18)
D00919 Cefotaxime sodium (JP18/USP)
D00921 Ceftazidime (USP); Ceftazidime hydrate (JP18)
D00924 Ceftriaxone sodium (USP); Ceftriaxone sodium hydrate (JP18)
D01739 Cefmenoxime hydrochloride (JP18/USP)
D00923 Ceftizoxime sodium (JP18/USP)
D07640 Cefixime (USP); Cefixime hydrate (JP18)
D00920 Cefpodoxime proxetil (JP18/USP)
D00917 Cefdinir (JP18/USP/INN)
D01628 Cefditoren pivoxil (JP18/USAN)
D01680 Cefcapene pivoxil hydrochloride hydrate (JP18)
D01686 Cefteram pivoxil (JP18)
D01157 Cefepime hydrochloride (USP); Cefepime dihydrochloride hydrate (JP18)
D02233 Cefozopran hydrochloride (JP18)
|
6133 Oxacephem antibioitics
|
6134 Amino sugars
|
6135 Fosfomycins
|
6139 Others
|
614 Acting mainly on gram-positive bacteria and mycoplasma
|
615 Acting mainly on gram-positive bacteria, gram-negative bacteria, rickettsia and chlamydia
|
616 Acting mainly on acid-fast bacteria
|
617 Acting mainly on mold
|
619 Miscellaneous
|
62 Chemotherapeutics
|
63 Biological preparations
|
64 Parasitics (systemic)
|
69 Other agents against pathogenic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan